Cargando…

Transhiatal vs extended transthoracic resection in oesophageal carcinoma: patients' utilities and treatment preferences

To assess patients' utilities for health state outcomes after transhiatal or transthoracic oesophagectomy for oesophageal cancer and to investigate the patients' treatment preferences for either procedure. The study group consisted of 48 patients who had undergone either transhiatal or tra...

Descripción completa

Detalles Bibliográficos
Autores principales: de Boer, A G E M, Stalmeier, P F M, Sprangers, M A G, de Haes, J C J M, van Sandick, J W, Hulscher, J B F, van Lanschot, J J B
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364156/
https://www.ncbi.nlm.nih.gov/pubmed/11953814
http://dx.doi.org/10.1038/sj.bjc.6600203
_version_ 1782153883256094720
author de Boer, A G E M
Stalmeier, P F M
Sprangers, M A G
de Haes, J C J M
van Sandick, J W
Hulscher, J B F
van Lanschot, J J B
author_facet de Boer, A G E M
Stalmeier, P F M
Sprangers, M A G
de Haes, J C J M
van Sandick, J W
Hulscher, J B F
van Lanschot, J J B
author_sort de Boer, A G E M
collection PubMed
description To assess patients' utilities for health state outcomes after transhiatal or transthoracic oesophagectomy for oesophageal cancer and to investigate the patients' treatment preferences for either procedure. The study group consisted of 48 patients who had undergone either transhiatal or transthoracic oesophagectomy. In an interview they were presented with eight possible health states following oesophagectomy. Visual Analogue Scale and standard gamble techniques were used to measure utilities. Treatment preference for either transhiatal or transthoracic oesophagectomy was assessed. Highest scores were found for the patients' own current health state (Visual Analogue Scale: 0.77; standard gamble: 0.97). Lowest scores were elicited for the health state ‘irresectable tumour’ (Visual Analogue Scale: 0.13; standard gamble: 0.34). The Visual Analogue Scale method produced lower estimates (P<0.001) than the standard gamble method for all health states. Most patient characteristics and clinical factors did not correlate with the utilities. Ninety-five per cent of patients who underwent a transthoracic procedure and 52% of patients who underwent a transhiatal resection would prefer the transthoracic treatment. No significant associations between any patient characteristics or clinical characteristics and treatment preference were found. Utilities after transhiatal or transthoracic oesophagectomy were robust because they generally did not vary by patient or clinical characteristics. Overall, most patients preferred the transthoracic procedure. British Journal of Cancer (2002) 86, 851–857. DOI: 10.1038/sj/bjc/6600203 www.bjcancer.com © 2002 Cancer Research UK
format Text
id pubmed-2364156
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23641562009-09-10 Transhiatal vs extended transthoracic resection in oesophageal carcinoma: patients' utilities and treatment preferences de Boer, A G E M Stalmeier, P F M Sprangers, M A G de Haes, J C J M van Sandick, J W Hulscher, J B F van Lanschot, J J B Br J Cancer Clinical To assess patients' utilities for health state outcomes after transhiatal or transthoracic oesophagectomy for oesophageal cancer and to investigate the patients' treatment preferences for either procedure. The study group consisted of 48 patients who had undergone either transhiatal or transthoracic oesophagectomy. In an interview they were presented with eight possible health states following oesophagectomy. Visual Analogue Scale and standard gamble techniques were used to measure utilities. Treatment preference for either transhiatal or transthoracic oesophagectomy was assessed. Highest scores were found for the patients' own current health state (Visual Analogue Scale: 0.77; standard gamble: 0.97). Lowest scores were elicited for the health state ‘irresectable tumour’ (Visual Analogue Scale: 0.13; standard gamble: 0.34). The Visual Analogue Scale method produced lower estimates (P<0.001) than the standard gamble method for all health states. Most patient characteristics and clinical factors did not correlate with the utilities. Ninety-five per cent of patients who underwent a transthoracic procedure and 52% of patients who underwent a transhiatal resection would prefer the transthoracic treatment. No significant associations between any patient characteristics or clinical characteristics and treatment preference were found. Utilities after transhiatal or transthoracic oesophagectomy were robust because they generally did not vary by patient or clinical characteristics. Overall, most patients preferred the transthoracic procedure. British Journal of Cancer (2002) 86, 851–857. DOI: 10.1038/sj/bjc/6600203 www.bjcancer.com © 2002 Cancer Research UK Nature Publishing Group 2002-03-18 /pmc/articles/PMC2364156/ /pubmed/11953814 http://dx.doi.org/10.1038/sj.bjc.6600203 Text en Copyright © 2002 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical
de Boer, A G E M
Stalmeier, P F M
Sprangers, M A G
de Haes, J C J M
van Sandick, J W
Hulscher, J B F
van Lanschot, J J B
Transhiatal vs extended transthoracic resection in oesophageal carcinoma: patients' utilities and treatment preferences
title Transhiatal vs extended transthoracic resection in oesophageal carcinoma: patients' utilities and treatment preferences
title_full Transhiatal vs extended transthoracic resection in oesophageal carcinoma: patients' utilities and treatment preferences
title_fullStr Transhiatal vs extended transthoracic resection in oesophageal carcinoma: patients' utilities and treatment preferences
title_full_unstemmed Transhiatal vs extended transthoracic resection in oesophageal carcinoma: patients' utilities and treatment preferences
title_short Transhiatal vs extended transthoracic resection in oesophageal carcinoma: patients' utilities and treatment preferences
title_sort transhiatal vs extended transthoracic resection in oesophageal carcinoma: patients' utilities and treatment preferences
topic Clinical
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364156/
https://www.ncbi.nlm.nih.gov/pubmed/11953814
http://dx.doi.org/10.1038/sj.bjc.6600203
work_keys_str_mv AT deboeragem transhiatalvsextendedtransthoracicresectioninoesophagealcarcinomapatientsutilitiesandtreatmentpreferences
AT stalmeierpfm transhiatalvsextendedtransthoracicresectioninoesophagealcarcinomapatientsutilitiesandtreatmentpreferences
AT sprangersmag transhiatalvsextendedtransthoracicresectioninoesophagealcarcinomapatientsutilitiesandtreatmentpreferences
AT dehaesjcjm transhiatalvsextendedtransthoracicresectioninoesophagealcarcinomapatientsutilitiesandtreatmentpreferences
AT vansandickjw transhiatalvsextendedtransthoracicresectioninoesophagealcarcinomapatientsutilitiesandtreatmentpreferences
AT hulscherjbf transhiatalvsextendedtransthoracicresectioninoesophagealcarcinomapatientsutilitiesandtreatmentpreferences
AT vanlanschotjjb transhiatalvsextendedtransthoracicresectioninoesophagealcarcinomapatientsutilitiesandtreatmentpreferences